This multicenter Phase II study hopes to confirm single institutional reports of whether radiation therapy (RT) to the groin combined with chemotherapy in patients with squamous or epidermoid carcinomas of the vulva will permit less extensive surgery than previously recommended. Surgery for these patients in the past involved local lymph node removal and frequently removal of parts of the anus, rectum, urethra, bladder, clitoris and vagina, depending on the extent of local spread. The patients will undergo RT 5 out of 7 days, to the local area coupled with two weeks of chemotherapy with 5-FU and Mitomycin-C. If there is sufficient tumor regression to allow for simple surgery, it will be performed 6 to 8 weeks after the course has been finished. If not, they will add 10 more RT treatments in conjuction with a third course of chemotherapy. Patients wilth nodal involvement will undergo resection of involved nodes followed by the above protocol. The objectives of this study are to assess the efficacy of this therapy as having less morbidity than conventional therapy, to measure the efficacy of initial chemoradiation in converting the status of locally advanced cancers of the vulva from unresectable to resectable.The following endpoints will be measured: freedom from relapse in groin nodes; rate of chemoradiotherapeutic conversion of locally extensive vulvar cancer from unresectable to resectable; freedom from relapse at the primary site, acute toxicities of treatment and late effects in normal tissues; and pattern of failure and causes of death.

Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
38
Fiscal Year
1999
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Homann, O R; Misura, K; Lamas, E et al. (2016) Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness. Mol Psychiatry 21:1690-1695
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Li, Yi; Tsui, Wai; Rusinek, Henry et al. (2015) Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease. J Nucl Med 56:270-3
Ghani, Mahdi; Reitz, Christiane; Cheng, Rong et al. (2015) Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. JAMA Neurol 72:1313-23
Beecham, Gary W; Dickson, Dennis W; Scott, William K et al. (2015) PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology 84:972-80

Showing the most recent 10 out of 470 publications